Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.83619 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.77509 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7771 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.70702 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.71153 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.89596 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.8254 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.74623 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.7298 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.76966 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.76479 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.72065 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.77426 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.76597 | 34 |